1. Razavi H, ElKhoury AC, Elbasha E, Estes C, Pasini K, Poynard T, et al. Chronic hepatitis C virus (HCV) disease burden and cost in the United States. Hepatology. 2013;57(6):2164-70.
2. Centers for Disease Control & Prevention. Hepatitis C FAQs for Health Professionals 2008. Available from: https://www.cdc.gov/hepatitis/hcv/hcvfaq.htm Retrieved September 15, 2017.
3. Zibbell JE, Iqbal K, Patel R, Suryaprasad A, Sanders K, Moore-Moravian L, et al. Increases in hepatitis C virus infection related to injection drug use among persons aged ≤ 30 years-Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012. MMWR Morb Mortal Wkly Rep. 2015;64(17):453-8.
4. Williford SE, McGivern DR. Mechanism of Action of Direct-Acting Antivirals: New Insights into the HCV Life Cycle. In: Miyamura T, Lemon S, Walker C, Wakita T, eds. Hepatitis C Virus II. Tokyo: Springer; 2016:287-301.
5. US Food and Drug Administration. Hepatitis B and C Treatments. 2017. Available from: https://www.fda.gov/ForPatients/Illness/HepatitisBC/ucm408658.htm . Retrieved July 14, 2017.